Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes
John R. White, Jr.
DOI: 10.2337/diaclin.34.2.86
A Case of Persistent Polyuria in an Insulin-Dependent Child With Diabetes
Swayamsidha Mangaraj, Arun Kumar Choudhury, Binoy Kumar Mohanty, and Anoj Kumar Baliarsinha
DOI: 10.2337/diaclin.34.2.109
Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?
Sharon W. Lahiri
DOI: 10.2337/diaclin.34.2.115
Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
Stephen A. Brunton, Davida F. Kruger, and Martha M. Funnell
DOI: 10.2337/diaclin.34.1.34
Pocketbook for management of diabetes in childhood and adolescence in under-resourced countries, 2nd edition
Treatment Approach to Patients With Severe Insulin Resistance
Timothy J. Church and Stuart T. Haines
DOI: 10.2337/diaclin.34.2.97
Alzheimer’s Disease Is Type 3 Diabetes—Evidence Reviewed
Suzanne M. de la Monte, M.D., M.P.H.1–3 and Jack R. Wands, M.D.3
J Diabetes Sci Technol 2008;2(6):1101-1113
The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
William R. Hiatt, M.D., Sanjay Kaul, M.D., and Robert J. Smith, M.D.
DOI: 10.1056/NEJMp1309610
Diabetic Sensory and Motor Neuropathy
Aaron I. Vinik, M.D., Ph.D.
N Engl J Med 2016;374:1455-64.
DOI: 10.1056/NEJMcp1503948
Acid–Base Problems in Diabetic Ketoacidosis
Kamel S. Kamel, M.D., and Mitchell L. Halperin, M.D.
N Engl J Med 2015;372:546-54.
DOI: 10.1056/NEJMra1207788
Rare Presentations of Ketoacidosis: Diabetic Ketoalkalosis and Ketoacidosis Secondary to Fasting and Muscular Dystrophy
Mads Vandsted Svart, Thomas Schmidt Voss, Michael Bayat, Lene Ring Madsen, Lone Thing Andersen, Per Løgstrup Poulsen, and Niels Møller
DOI: 10.2337/diaclin.33.1.37
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
DOI: 10.1161/01.cir.0000437738.63853.7a
This Time, FDA Panel Endorses Diabetes Drug Dapagliflozin
Miriam E. Tucker
December 13, 2013
World First Approval for Fenofibrate in Diabetic Retinopathy
( November 29, 2013)
FDA Lifts Rosiglitazone Prescribing Restrictions (November 25, 2013)
http://www.medscape.com/viewarticle/814964
Oman Diabetes Association
Sultanate of Oman – Muscat – Boushar opposite of Oman LLNG Al Jama’a AlAkbar Street ، Building No: 1/315، Room Number: 23.